Mechanisms of obesity-induced hypertensionVasilios Kotsis, Gianfranco Parati|Hypertension Research|2010Cited by 625
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel StatementVasilios G. Athyros, Christos S. Mantzoros, Michael Doumas et al.|Metabolism|2017Cited by 251
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challengesMichail Kokkorakis, Christos S. Mantzoros, Chrysoula Boutari et al.|Metabolism|2024Cited by 138